Christina DiArcangelo Puller, CEO and Founder of Affinity Bio Partners, CEO, Board President of Affinity Patient Advocacy and CEO and Co-Founder of AI Health Outcomes, CannaBotTM, has forged a world-class reputation in the Biotechnology and Pharmaceutical industry for the past 20 years. Her engagements have led to numerous industry awards, keynote speaking engagements, multitude of global clinical trials as well as working on several drugs that have received FDA approval and the ultimate respect of her industry peers. Throughout the course of Christina's career, she has acted in various capacities for Global Clinical Research Organizations, Pharmaceutical Companies and Biotechnology Companies. Christina's professional success and drive has been facilitated by her unwavering strength as a contracts negotiator, visionary entrepreneur, skilled clinical research operations expert and her ability to successfully navigate the pharmaceutical industry with unparalleled success. Recently, she has launched a YouTube Channel called, “Coming Out with Cannabis” and is an American Society of Cannabis Medicine (“ASCM”) board member working on clinical research through the ASCM. "My strong work ethic, coupled with my motivation, drive to keep learning, growing and pushing the limits: have helped me reach many of my professional goals.